Medical Marijuana, Inc.'s CBD Products Discounted in Celebration of 2018 Olympic Games

Wednesday, February 21, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

SAN DIEGO, Feb. 21, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company

in the United States, today announced that it is excited to celebrate the 2018 Olympic Games with discounts on its tetrahydrocannabinol (THC)-free cannabidiol (CBD) hemp oil products designed specifically for athletes
and those who are subject to drug tests.

It's no secret that cannabis is becoming increasingly popular as a pain management supplement in the U.S., and specifically is becoming a more widely recognized treatment option for professional athletes who are constantly experiencing a variety of injuries. In fact, according to a Yahoo/Marist College Poll, nearly 70% of Americans approve of athletes using cannabis for pain.

"We are excited to be able to celebrate the dedication and hard work of Olympians from all over the world and make our CBD products more accessible to those who need it most," said Medical Marijuana, Inc. CEO Dr. Stuart Titus. "We're happy that the World Anti-Doping Agency understands that CBD is safe for professional athletes to use and has many health and wellness benefits."

WADA removed CBD from its list of prohibited substances as of Jan. 1, 2018, stating that: "Recent scientific literature shows that synthetic cannabidiol is not a cannabimimetic. Therefore, cannabidiol no longer fulfills two of the three criteria to be considered for inclusion on the list."

Medical Marijuana, Inc.'s CBD hemp oil, Real Scientific Hemp Oil-X™ (RSHO-X™), is perfect for athletes because it is free of THC, the compound found in cannabis that is known to get you high. It has become the CBD supplement of choice not only for athletes, but also for small children, first responders and anyone else who is subject to drug tests.

In addition to WADA's recent statement, the World Health Organization made a recommendation in November 2017 not to schedule CBD as a drug stating that, "In its pure state, cannabidiol does not appear to have abuse potential or cause harm," and that "current information does not justify scheduling of the substance."

From today until Feb. 25, 2018, Medical Marijuana, Inc. is offering a 20% discount on RSHO-X™ products. To learn more, please visit:

About Medical Marijuana, Inc.

We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit

To see Medical Marijuana, Inc.'s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.'s shop.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.


These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

LEGAL DISCLOSUREMedical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

CONTACT:Public Relations Contact:Andrew HardChief Executive Officer CMW MediaP.


Cision View original content:

SOURCE Medical Marijuana, Inc.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store